GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Essex Bio-Technology Ltd (HKSE:01061) » Definitions » Equity-to-Asset

Essex Bio-Technology (HKSE:01061) Equity-to-Asset : 0.71 (As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Essex Bio-Technology Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Essex Bio-Technology's Total Stockholders Equity for the quarter that ended in Dec. 2024 was HK$2,124 Mil. Essex Bio-Technology's Total Assets for the quarter that ended in Dec. 2024 was HK$2,983 Mil. Therefore, Essex Bio-Technology's Equity to Asset Ratio for the quarter that ended in Dec. 2024 was 0.71.

The historical rank and industry rank for Essex Bio-Technology's Equity-to-Asset or its related term are showing as below:

HKSE:01061' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.58   Med: 0.64   Max: 0.71
Current: 0.71

During the past 13 years, the highest Equity to Asset Ratio of Essex Bio-Technology was 0.71. The lowest was 0.58. And the median was 0.64.

HKSE:01061's Equity-to-Asset is ranked better than
67.64% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 0.61 vs HKSE:01061: 0.71

Essex Bio-Technology Equity-to-Asset Historical Data

The historical data trend for Essex Bio-Technology's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Essex Bio-Technology Equity-to-Asset Chart

Essex Bio-Technology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.59 0.61 0.64 0.68 0.71

Essex Bio-Technology Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.64 0.64 0.68 0.68 0.71

Competitive Comparison of Essex Bio-Technology's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Essex Bio-Technology's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Essex Bio-Technology's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Essex Bio-Technology's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Essex Bio-Technology's Equity-to-Asset falls into.


;
;

Essex Bio-Technology Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Essex Bio-Technology's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Equity to Asset (A: Dec. 2024 )=Total Stockholders Equity/Total Assets
=2123.72/2983.045
=0.71

Essex Bio-Technology's Equity to Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

Equity to Asset (Q: Dec. 2024 )=Total Stockholders Equity/Total Assets
=2123.72/2983.045
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Essex Bio-Technology  (HKSE:01061) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Essex Bio-Technology Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Essex Bio-Technology's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Essex Bio-Technology Business Description

Traded in Other Exchanges
N/A
Address
No. 88, Keji 6th Road, Hi-Tech Zone, Guangdong, Zhuhai, CHN
Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture and sale of biologic drugs in the People's Republic of China. The company is made up of segments of Ophthalmology products and Surgical products. Its products under Ophthalmology include the Beifushu series, Tobramycin Eye Drops, Levofloxacin Eye Drops, Sodium Hyaluronate Eye Drops. The products under Surgical include the Beifuji series, Carisolv dental caries removal gel and mouth wash. The majority of the groups revenue comes from PRC.
Executives
Lauw Hui Kian
Ngiam Mia Je Patrick
Ngiam Mia Kiat Benjamin 2101 Beneficial owner

Essex Bio-Technology Headlines

No Headlines